| Primary |
| Nuclear Magnetic Resonance Imaging |
41.0% |
| Nuclear Magnetic Resonance Imaging Brain |
15.3% |
| Angiogram |
9.8% |
| Diagnostic Procedure |
9.5% |
| Nuclear Magnetic Resonance Imaging Abdominal |
4.6% |
| Multiple Myeloma |
2.4% |
| Hepatic Neoplasm Malignant |
2.0% |
| Angioplasty |
1.7% |
| Metastases To Central Nervous System |
1.7% |
| Renal Scan |
1.7% |
| Haemorrhage Intracranial |
1.4% |
| Back Pain |
1.1% |
| Headache |
1.1% |
| Cardiac Failure Congestive |
1.0% |
| Coronary Artery Disease |
1.0% |
| Hypertension |
1.0% |
| Investigation |
1.0% |
| Metastasis |
1.0% |
| Renal Artery Stenosis |
1.0% |
| Renal Failure Chronic |
1.0% |
|
| Nephrogenic Systemic Fibrosis |
29.4% |
| Hypersensitivity |
11.7% |
| Shock |
10.2% |
| Anaphylactic Reaction |
7.9% |
| Urticaria |
6.0% |
| Anaphylactic Shock |
5.7% |
| Vomiting |
4.2% |
| Dyspnoea |
3.4% |
| Anaphylactoid Reaction |
2.6% |
| Respiratory Arrest |
2.3% |
| Anaphylactoid Shock |
1.9% |
| Loss Of Consciousness |
1.9% |
| Nausea |
1.9% |
| Nephrogenic Fibrosing Dermopathy |
1.9% |
| Pulse Absent |
1.9% |
| Wheezing |
1.9% |
| Throat Tightness |
1.5% |
| Tremor |
1.5% |
| Circulatory Collapse |
1.1% |
| Convulsion |
1.1% |
|
| Secondary |
| Nuclear Magnetic Resonance Imaging |
56.3% |
| Angiogram |
14.1% |
| Imaging Procedure |
4.6% |
| Drug Use For Unknown Indication |
4.6% |
| Nuclear Magnetic Resonance Imaging Brain |
3.9% |
| Product Used For Unknown Indication |
3.6% |
| Nuclear Magnetic Resonance Imaging Abdominal |
2.3% |
| Diagnostic Procedure |
1.7% |
| Fistulogram |
1.4% |
| Venogram |
1.3% |
| Pain |
1.2% |
| Hypertension |
1.2% |
| Anaemia |
0.8% |
| Angioplasty |
0.5% |
| Scan |
0.5% |
| Diabetes Mellitus |
0.4% |
| Prophylaxis Against Transplant Rejection |
0.4% |
| Arteriogram |
0.4% |
| Blood Pressure Abnormal |
0.3% |
| Cardiac Disorder |
0.3% |
|
| Pain |
21.9% |
| Skin Tightness |
16.0% |
| Nephrogenic Systemic Fibrosis |
14.6% |
| Skin Fibrosis |
10.8% |
| Scar |
9.8% |
| Skin Induration |
5.0% |
| Skin Hypertrophy |
2.6% |
| Skin Ulcer |
2.6% |
| Swelling |
2.3% |
| Anxiety |
1.7% |
| Shock |
1.5% |
| Joint Range Of Motion Decreased |
1.4% |
| Mobility Decreased |
1.4% |
| Pruritus |
1.4% |
| Xerosis |
1.4% |
| Oedema Peripheral |
1.3% |
| Emotional Distress |
1.2% |
| Injury |
1.1% |
| Skin Discolouration |
1.1% |
| Pain In Extremity |
1.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
12.9% |
| Cancer Pain |
10.3% |
| Meningitis |
10.3% |
| Bacterial Infection |
8.6% |
| Meningitis Haemophilus |
8.6% |
| Nuclear Magnetic Resonance Imaging |
6.9% |
| Sedation |
5.2% |
| Upper Respiratory Tract Inflammation |
5.2% |
| Bronchitis |
3.4% |
| Disseminated Intravascular Coagulation |
3.4% |
| Gastroenteritis |
3.4% |
| Glaucoma |
3.4% |
| Prophylaxis |
3.4% |
| Acoustic Neuroma |
2.6% |
| Angiogram |
2.6% |
| Hydrocephalus |
2.6% |
| Cataract |
1.7% |
| Constipation |
1.7% |
| Convulsion |
1.7% |
| Gastric Ulcer |
1.7% |
|
| Nephrogenic Systemic Fibrosis |
65.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.9% |
| Interstitial Lung Disease |
6.9% |
| Renal Transplant |
6.9% |
| Shock Hypoglycaemic |
3.4% |
| Skin Lesion |
3.4% |
| Sudden Cardiac Death |
3.4% |
| Upper Respiratory Tract Infection |
3.4% |
|
